Medicure Stock Fundamentals
| MCUJF Stock | USD 0.70 0.00 0.00% |
Medicure fundamentals help investors to digest information that contributes to Medicure's financial success or failures. It also enables traders to predict the movement of Medicure Pink Sheet. The fundamental analysis module provides a way to measure Medicure's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medicure pink sheet.
Medicure |
Medicure Company Return On Asset Analysis
Medicure's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medicure Return On Asset | 0.021 |
Most of Medicure's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medicure is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Medicure has a Return On Asset of 0.021. This is 100.24% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The return on asset for all United States stocks is 115.0% lower than that of the firm.
Medicure Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medicure's current stock value. Our valuation model uses many indicators to compare Medicure value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medicure competition to find correlations between indicators driving Medicure's intrinsic value. More Info.Medicure is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.14 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medicure is roughly 7.06 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medicure's earnings, one of the primary drivers of an investment's value.Medicure Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medicure's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Medicure could also be used in its relative valuation, which is a method of valuing Medicure by comparing valuation metrics of similar companies.Medicure is currently under evaluation in return on asset category among its peers.
Medicure Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.021 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 5.67 M | |||
| Shares Outstanding | 10.25 M | |||
| Shares Owned By Insiders | 26.70 % | |||
| Shares Owned By Institutions | 23.51 % | |||
| Number Of Shares Shorted | 15.08 K | |||
| Price To Earning | 11.45 X | |||
| Price To Book | 0.57 X | |||
| Price To Sales | 0.37 X | |||
| Revenue | 21.74 M | |||
| Gross Profit | 12.71 M | |||
| EBITDA | 2.42 M | |||
| Net Income | (727 K) | |||
| Cash And Equivalents | 4.83 M | |||
| Cash Per Share | 0.47 X | |||
| Total Debt | 1.02 M | |||
| Debt To Equity | 0.05 % | |||
| Current Ratio | 1.47 X | |||
| Book Value Per Share | 2.04 X | |||
| Cash Flow From Operations | 3.99 M | |||
| Short Ratio | 1.77 X | |||
| Earnings Per Share | 0.21 X | |||
| Price To Earnings To Growth | (23.59) X | |||
| Target Price | 0.13 | |||
| Number Of Employees | 12 | |||
| Beta | 1.05 | |||
| Market Capitalization | 9.24 M | |||
| Total Asset | 28.41 M | |||
| Retained Earnings | (89.95 M) | |||
| Working Capital | 5.11 M | |||
| Current Asset | 12.56 M | |||
| Current Liabilities | 7.45 M | |||
| Z Score | 1.2 | |||
| Net Asset | 28.41 M |
About Medicure Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medicure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada. Medicure is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Medicure Pink Sheet
Medicure financial ratios help investors to determine whether Medicure Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicure with respect to the benefits of owning Medicure security.